首页> 美国卫生研究院文献>The Journal of Clinical Endocrinology and Metabolism >Statins Inhibit Growth of Human Theca-Interstitial Cells in PCOS and Non-PCOS Tissues Independently of Cholesterol Availability
【2h】

Statins Inhibit Growth of Human Theca-Interstitial Cells in PCOS and Non-PCOS Tissues Independently of Cholesterol Availability

机译:他汀类药物抑制PCOS和非PCOS组织中人类Theca-间质细胞的生长与胆固醇的可用性无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Context: Polycystic ovary syndrome (PCOS) is associated with ovarian enlargement, prominent theca-interstitial hyperplasia, and excessive androgen production. Recent clinical trials have demonstrated that statins, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors, decrease androgen levels in women with PCOS.>Objective: The present study evaluated the effect of statins on proliferation of human ovarian theca-interstitial cells.>Design and Settings: In vitro experiments were performed in the university research laboratory.>Patients: Human theca-interstitial cells were isolated from ovaries of PCOS (n = 4) and non-PCOS (n = 4) patients.>Main Outcome Measures: The cells were incubated for 48 h without additives (control) or with simvastatin (3–30 μm), mevastatin (3–30 μm), and/or the cell- and mitochondrion-permeable form of cholesterol (22-hydroxycholesterol; 10 μm). To determine whether the effects of statins could be affected by leukocytes, the experiment was carried out on cells not purified of leukocytes and cells purified using anti-CD-45 immunomagnetic beads. The effect of statins on proliferation was evaluated by determination of DNA synthesis using radiolabeled thymidine-incorporation assay and by quantification of viable cells using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenil)-2H-tetrazolium assay.>Results: Statins induced an inhibition of DNA synthesis in both the absence and the presence of 22-hydroxycholesterol; furthermore, 22-hydroxycholesterol alone also inhibited DNA synthesis. These effects of statins and 22-hydroxycholesterol were confirmed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenil)-2H-tetrazolium assay. Comparable inhibition of proliferation was observed in cells obtained from women with and without PCOS and in cell preparations treated and not treated with anti-CD-45 immunomagnetic beads.>Conclusions: Statins inhibit proliferation of human theca-interstitial cells irrespective of the availability of cholesterol and independently of leukocytes both in normal and PCOS ovaries.
机译:>背景:多囊卵巢综合征(PCOS)与卵巢增大,明显的间质增生和雄激素过多有关。最近的临床试验表明,他汀类药物,3-羟基-3-甲基-戊二酰辅酶A还原酶抑制剂可降低PCOS妇女的雄激素水平。>目的:本研究评估了他汀类药物对PCOS增殖的影响。人卵巢间质细胞。>设计和设置:在大学研究实验室进行了体外实验。>患者:人间质细胞是从PCOS卵巢中分离得到的( n = 4)和非PCOS(n = 4)患者。>主要结果指标:细胞在无添加剂(对照)或与辛伐他汀(3-30μm),美伐他汀( 3–30μm),和/或胆固醇(22-羟基胆固醇; 10μm)的细胞和线粒体可渗透形式。为了确定他汀类药物的作用是否会受到白细胞的影响,对未纯化白细胞的细胞和使用抗CD-45免疫磁珠纯化的细胞进行了实验。他汀类药物对增殖的影响通过放射性标记的胸苷掺入法测定DNA合成并使用3-(4,5-二甲基噻唑-2-基)-5-(3-羧基甲氧基苯基)-2-对活细胞进行定量来评估(4-噻吩基)-2H-四唑鎓测定。>结果:在不存在和存在22-羟基胆固醇的情况下,他汀类药物均可抑制DNA合成。此外,单独的22-羟基胆固醇也抑制DNA合成。他汀类药物和22-羟基胆固醇的这些作用通过3-(4,5-二甲基噻唑-2-基)-5-(3-羧基甲氧基苯基)-2-(4-噻吩基)-2H-四唑鎓测定法得以证实。在有和没有PCOS的女性细胞以及用和未用抗CD-45免疫磁珠治疗的细胞制剂中观察到的细胞增殖均具有同等的抑制作用。>结论:他汀类药物抑制人卵泡间质细胞的增殖无论在正常卵巢还是在PCOS卵巢中,无论胆固醇的可用性如何,都与白细胞无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号